Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2007
07/11/2007EP1804786A2 Substituted n-aryl-9-oxo-9h-fluorene-1-carboxamides and analogs as activators of caspases and inducers of apoptosis
07/11/2007EP1804782A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease
07/11/2007EP1804772A1 Granules comprising a nsaid and a sugar alcohol made by melt extrusion
07/11/2007EP1461361B1 Negatively charged polysaccharide derivable from aloe vera
07/11/2007EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
07/11/2007EP1303265B1 Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids
07/11/2007EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407
07/11/2007EP1105467B1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
07/11/2007EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents
07/11/2007EP0975771B1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
07/11/2007CN1997655A Pyridyl-substituted porphyrin compounds and methods of use thereof
07/11/2007CN1997369A Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
07/11/2007CN1995061A Cyclamin I and its preparation method and pharmaceutical composition
07/11/2007CN1995060A Cyclamin A and its preparation method and use thereof
07/11/2007CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/11/2007CN1995019A Kukoline salt compounds and its preparation method
07/11/2007CN1994457A Swelling-relieving pain-stopping externally applied ointment
07/11/2007CN1994453A Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis
07/11/2007CN1994452A Orally administered Chinese medicine for treating functional dysmenorrhea
07/11/2007CN1994441A Pain-relieving oral liquid with nut-vomitive posonnut seed for treating cervical and lumbar disease
07/11/2007CN1994430A Externally applied ointment for activating blood circulation and unblocking obstruction
07/11/2007CN1994429A Pharmaceutical composition for treating inflammation and preparation process thereof
07/11/2007CN1994428A Chinese medicine for treating ischemic necrosis of femoral head
07/11/2007CN1994418A Thin film coated tablet with sea snake for treating arthritis and preparation method thereof
07/11/2007CN1994415A Orally administered medicine for treating dysmenorrhea
07/11/2007CN1994404A Chinese medicinal pill for treating lumbar and leg pain
07/11/2007CN1994401A Chinese medicinal capsule for treating joint pain and hyperosteogeny
07/11/2007CN1994393A Orally administered Chinese medicine for treating heat type dysmenorrhea
07/11/2007CN1994390A Chinese medicine for treating dysmenorrhea
07/11/2007CN1994388A Medicinal liquid for eliminating swelling and stopping pain
07/11/2007CN1994380A Externally applied medicine for treating arthritis, hot pack and preparation method thereof
07/11/2007CN1994379A Method for preparing total saponin of radde anemone rhizome
07/11/2007CN1994358A Chinese medicinal formulation for treating rheumatic and rheumatoid arthritis and preparation process thereof
07/11/2007CN1994352A Use of total glucosides extract of cocklebur fruit in preparation of product for resisting inflammatory reaction
07/11/2007CN1994343A Pharmaceutical composition having functions in activating blood and invigorating qi and preparation process thereof
07/11/2007CN1994308A Pain-relieving medicinal ointment
07/11/2007CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof
07/11/2007CN1994104A Constipation-relieving tea with snow lotus fruit, cassia seed and arctium fruit and preparation process thereof
07/11/2007CN1325651C High-efficiency expression and application of human recombinant interferon B
07/11/2007CN1325514C Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method
07/11/2007CN1325498C Novel crystalline compound
07/11/2007CN1325497C Pharmaceutically active isoindoline derivs.
07/11/2007CN1325493C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
07/11/2007CN1325491C Novel crystals
07/11/2007CN1325480C Novel phenylalanine derivatives
07/11/2007CN1325479C Pyrimidine compounds
07/11/2007CN1325110C Medicated wine for treating traumatic injury
07/11/2007CN1325070C Chinese traditional medicine Tripterygium wilfordii and improving technique for attenuation and synergy of its extract
07/11/2007CN1325058C Application of sodium selenite in preparation of medicine for treating wind, dampness and cold caused arthralgia
07/11/2007CN1325045C Qingkailing dispersing tablet
07/10/2007US7241890 Heat shock protein 90 inhibitors; breast cancer, melanomas; inflammation, infectious diseases, autoimmune disorders, ischemia
07/10/2007US7241873 Recombinant anti-osteopontin antibody and use thereof
07/10/2007US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same
07/10/2007US7241860 Transcription factor polypeptide that regulates Chondromodulin-I expression
07/10/2007US7241791 Substituted 4-(indazol-3-yl)phenols
07/10/2007US7241789 Substituted indoles and their use as integrin antagonists
07/10/2007US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases
07/10/2007US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/10/2007US7241747 For therapy and prophylaxis of diseases where bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; also exhibit pronounced activity in arresting the proliferation of undifferentiated cells
07/10/2007US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
07/10/2007US7241619 Identification of genes encoding enzymes (Thraustochytrium aureum Delta 5-desaturase, Saprolegnia diclina Delta 5-desaturase, Saprolegnia diclina Delta 6-desaturase)involved in synthesis of polyunsaturated fatty acids
07/10/2007US7241618 A polynucleotide comprising a RNA polymerase promoter, able encoding a siRNA; treating cancer and genetic disorders; genetic engineering, inhibit gene expression of a target gene
07/10/2007US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to
07/10/2007US7241460 Strontium compound for treatment of sub-dermal soft tissue pain
07/10/2007US7240785 Method and apparatus for transferring substrates
07/10/2007CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them
07/10/2007CA2380072C Nicotine in therapeutic angiogenesis and vasculogenesis
07/10/2007CA2199401C Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
07/05/2007WO2007076104A1 Vanilloid receptor ligands and their use in treatments
07/05/2007WO2007075752A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
07/05/2007WO2007075688A2 Substituted aniline derivatives useful as histamine h3 antagonists
07/05/2007WO2007074940A1 P2x4 receptor antagonist
07/05/2007WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity
07/05/2007WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof
07/05/2007WO2007074604A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
07/05/2007WO2007073785A1 Therapeutic use of an extract from the leaves of nerium oleander
07/05/2007US20070157326 Ee3-protein family and corresponding dna sequence
07/05/2007US20070155817 Indolylmaleimide derivatives
07/05/2007US20070155812 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents
07/05/2007US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid
07/05/2007US20070155803 Protease inhibitors
07/05/2007US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
07/05/2007US20070155759 Using 1-acylpiperidine substance P antagonists; gastrointestinal disorders, analgesics, antiinflammatory agents, central nervous system disorders, rheumatic diseases
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
07/05/2007US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression
07/05/2007US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
07/05/2007US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
07/05/2007US20070155703 Pharmaceutically active compounds and methods of use thereof
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007US20070155002 Amino acid sequence from active principles in musk and their acetic salts, preparation and use thereof
07/05/2007US20070154991 Transgenic bacillus for use as bioreactor in production of capsular polysaccharide A
07/05/2007US20070154912 87 Human Secreted Proteins
07/05/2007DE102005062991A1 Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln Substituted thiazoles and their use for the preparation of medicaments
07/05/2007DE102005062990A1 Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln Substituted thiazoles and their use for the preparation of medicaments
07/05/2007DE102005062987A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments
07/05/2007DE102005062986A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments
07/05/2007DE102005062985A1 Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted bis (hetero) aromatic N-Ethylpropiolamide and their use for the preparation of medicaments
07/05/2007DE102005061430A1 Substituierte Imidazolin-Derivate Substituted imidazoline derivatives